1. Home
  2. NCSM vs ICCC Comparison

NCSM vs ICCC Comparison

Compare NCSM & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCS Multistage Holdings Inc.

NCSM

NCS Multistage Holdings Inc.

HOLD

Current Price

$47.00

Market Cap

112.0M

Sector

Energy

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$11.21

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCSM
ICCC
Founded
2006
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.0M
93.1M
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
NCSM
ICCC
Price
$47.00
$11.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.5K
26.6K
Earning Date
04-29-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
239.22
53.85
EPS
N/A
0.21
Revenue
$142,471,000.00
$26,493,169.00
Revenue This Year
$5.57
N/A
Revenue Next Year
$4.81
N/A
P/E Ratio
N/A
$52.67
Revenue Growth
N/A
51.64
52 Week Low
$29.48
$4.52
52 Week High
$87.36
$12.10

Technical Indicators

Market Signals
Indicator
NCSM
ICCC
Relative Strength Index (RSI) 45.09 56.42
Support Level $42.43 $5.90
Resistance Level $46.14 $12.10
Average True Range (ATR) 1.61 0.48
MACD 0.20 -0.05
Stochastic Oscillator 26.04 32.17

Price Performance

Historical Comparison
NCSM
ICCC

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completion, and field development strategies. The company provides its products and services to E&P companies for use in onshore and offshore wells, predominantly those drilled with horizontal laterals in unconventional and conventional oil and natural gas formations. It also provides tracer diagnostics services and sells products for well construction including casing buoyancy systems, liner hanger systems and toe initiation sleeves, along with certain complementary products from third parties. The company operates in the United States, Canada and other countries, with the majority of its revenue generated from Canada.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: